The search result changed since you submitted your search request. Documents might be displayed in a different sort order.
  • search hit 4 of 18
Back to Result List

Dose coverage comparison between "interstitial catheter-only" and "hybrid intracavitary-interstitial brachytherapy" for early stage squamous cell carcinoma of the buccal mucosa

  • Purpose: When squamous cell carcinoma of the buccal mucosa (BSCC) extends surrounding anatomical sites such as gingiva, retromolar triangle, or hard palate, it might be challenging to ensure adequate tumor coverage by sole interstitial brachytherapy due to the complexity of catheter implantation. By combining interstitial catheters with an enoral placed, individually assembled “oral spacer plus embedded catheters” device (hybrid of intracavitary-interstitial brachytherapy), it should be easier to deliver the necessary tumoricidal dose to irregular-shaped tumor volumes (clinical target volume – CTV) with improved conformity. The purpose of this analysis was to compare the dose distribution created by the hybrid of intracavitary-interstitial brachytherapy (HBT) with the dose distribution of an interstitial catheter only-approach, based on the interstitial catheters used for HBT (ISBT-only) by evaluating respective treatment plans (HBT plan vs. ISBT-only plan) for the treatment of early stage BSCC. Material and methods: A retrospective analysis was performed for patients with localized BSCC treated between April 2013 and October 2017. All patients received sole HBT without additional external beam radiation therapy or planned neck dissection. Dosimetric parameters taken into account for comparison between actual HBT and virtual ISBT-only were CTV D90, CTV V100, CTV V150, CTV V200, mandible D2cc, and mucosal surface D2cc. Results: Dosimetrically, HBT showed a trend toward better CTV D90 compared to ISBT-only. In addition, HBT demonstrated statistically better CTV V100 coverage compared to ISBT-only. There was no statistically significant difference with respect to CTV V150, CTV V200, and mucosal surface D2cc, while a trend was seen in better mandible D0.1cc between HBT and ISBT-only. Conclusions: The HBT approach appears to enable improved dose coverage of irregular-shaped enoral tumor volumes compared to ISBT-only for patients with early stage BSCC.

Download full text files

Export metadata

Metadaten
Author:Naoya Murakami, Takao Ueno, Wakako Yatsuoka, Hiroyuki Okamoto, Nikolaos TselisGND, Koji Masui, Ken Yoshida, Kana Takahashi, Koji Inaba, Kae Okuma, Hiroshi Igaki, Yuko Nakayama, Jun Itami
URN:urn:nbn:de:hebis:30:3-484530
DOI:https://doi.org/10.5114/jcb.2018.79471
ISSN:2081-2841
ISSN:1689-832X
Pubmed Id:https://pubmed.ncbi.nlm.nih.gov/30479628
Parent Title (English):Journal of contemporary brachytherapy
Publisher:Termedia
Place of publication:Poznań
Document Type:Article
Language:English
Year of Completion:2018
Date of first Publication:2018/10/30
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Release Date:2018/12/06
Tag:brachytherapy; buccal mucosa; hybrid; interstitial brachytherapy; squamous cell carcinoma
Volume:10
Issue:5
Page Number:6
First Page:486
Last Page:491
Note:
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
HeBIS-PPN:440677025
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung-Keine kommerzielle Nutzung-Weitergabe unter gleichen Bedingungen

OPUS4 Logo